BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26663347)

  • 1. Effects of the scaffold proteins liprin-α1, β1 and β2 on invasion by breast cancer cells.
    Chiaretti S; Astro V; Chiricozzi E; de Curtis I
    Biol Cell; 2016 Mar; 108(3):65-75. PubMed ID: 26663347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Liprins in the Regulation of Tumor Cell Motility and Invasion.
    Chiaretti S; de Curtis I
    Curr Cancer Drug Targets; 2016; 16(3):238-48. PubMed ID: 26882029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liprin-α1 regulates breast cancer cell invasion by affecting cell motility, invadopodia and extracellular matrix degradation.
    Astro V; Asperti C; Cangi MG; Doglioni C; de Curtis I
    Oncogene; 2011 Apr; 30(15):1841-9. PubMed ID: 21151172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and functional characterization of the interaction between liprin-α1 and GIT1: implications for the regulation of cell motility.
    Asperti C; Astro V; Pettinato E; Paris S; Bachi A; de Curtis I
    PLoS One; 2011; 6(6):e20757. PubMed ID: 21695141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liprin-α1 modulates cancer cell signaling by transmembrane protein CD82 in adhesive membrane domains linked to cytoskeleton.
    Pehkonen H; Lento M; von Nandelstadh P; Filippou A; Grénman R; Lehti K; Monni O
    Cell Commun Signal; 2018 Jul; 16(1):41. PubMed ID: 30005669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK2 drives tumour cell migration in three-dimensional microenvironments by suppressing expression of Rab17 and liprin-β2.
    von Thun A; Birtwistle M; Kalna G; Grindlay J; Strachan D; Kolch W; von Kriegsheim A; Norman JC
    J Cell Sci; 2012 Mar; 125(Pt 6):1465-77. PubMed ID: 22328529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional interaction between liprin-α1 and B56γ regulatory subunit of protein phosphatase 2A supports tumor cell motility.
    Ripamonti M; Lamarca A; Davey NE; Tonoli D; Surini S; de Curtis I
    Commun Biol; 2022 Sep; 5(1):1025. PubMed ID: 36171301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liprin-α1, ERC1 and LL5 define polarized and dynamic structures that are implicated in cell migration.
    Astro V; Chiaretti S; Magistrati E; Fivaz M; de Curtis I
    J Cell Sci; 2014 Sep; 127(Pt 17):3862-76. PubMed ID: 24982445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liprin-α1 contributes to oncogenic MAPK signaling by counteracting ERK activity.
    Pehkonen H; Filippou A; Väänänen J; Lindfors I; Vänttinen M; Ianevski P; Mäkelä A; Munne P; Klefström J; Toppila-Salmi S; Grénman R; Hagström J; Mäkitie AA; Karhemo PR; Monni O
    Mol Oncol; 2024 Mar; 18(3):662-676. PubMed ID: 38264964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1.
    Shen JC; Unoki M; Ythier D; Duperray A; Varticovski L; Kumamoto K; Pedeux R; Harris CC
    Cancer Res; 2007 Mar; 67(6):2552-8. PubMed ID: 17363573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
    Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
    Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chelidonine suppresses migration and invasion of MDA-MB-231 cells by inhibiting formation of the integrin-linked kinase/PINCH/α-parvin complex.
    Kim O; Hwangbo C; Kim J; Li DH; Min BS; Lee JH
    Mol Med Rep; 2015 Aug; 12(2):2161-8. PubMed ID: 25890994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liprin-alpha1 promotes cell spreading on the extracellular matrix by affecting the distribution of activated integrins.
    Asperti C; Astro V; Totaro A; Paris S; de Curtis I
    J Cell Sci; 2009 Sep; 122(Pt 18):3225-32. PubMed ID: 19690048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liprin-alpha1 affects the distribution of low-affinity beta1 integrins and stabilizes their permanence at the cell surface.
    Asperti C; Pettinato E; de Curtis I
    Exp Cell Res; 2010 Apr; 316(6):915-26. PubMed ID: 20096687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liprin-α1 and ERC1 control cell edge dynamics by promoting focal adhesion turnover.
    Astro V; Tonoli D; Chiaretti S; Badanai S; Sala K; Zerial M; de Curtis I
    Sci Rep; 2016 Sep; 6():33653. PubMed ID: 27659488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liprin-α1 is a regulator of vimentin intermediate filament network in the cancer cell adhesion machinery.
    Pehkonen H; von Nandelstadh P; Karhemo PR; Lepikhova T; Grenman R; Lehti K; Monni O
    Sci Rep; 2016 Apr; 6():24486. PubMed ID: 27075696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The β 2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB- 231 Cell Line.
    Rivero EM; Piñero CP; Gargiulo L; Entschladen F; Zänker K; Bruzzone A; Lüthy IA
    Curr Cancer Drug Targets; 2017; 17(8):756-766. PubMed ID: 28359245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyses of the spatiotemporal expression and subcellular localization of liprin-α proteins.
    Zürner M; Mittelstaedt T; tom Dieck S; Becker A; Schoch S
    J Comp Neurol; 2011 Oct; 519(15):3019-39. PubMed ID: 21618221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liprin beta 1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-associated protein S100A4 (Mts1).
    Kriajevska M; Fischer-Larsen M; Moertz E; Vorm O; Tulchinsky E; Grigorian M; Ambartsumian N; Lukanidin E
    J Biol Chem; 2002 Feb; 277(7):5229-35. PubMed ID: 11836260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.